Observational Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Apr 7, 2016; 22(13): 3652-3662
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3652
Table 1 Inclusion and exclusion criteria of the enrolled patients
Eligibility criteriaExclusion criteria
Histopathology confirmedMRI examination contraindication
Non-invasive diagnosis criteria [(EASL) 2012]1Significant renal insufficiency
Cirrhotic patients
Hypervascular in the arterial phase
Washout in the portal venous or delayed phase
Non-antineoplaston therapySevere motion artifacts on MRI images
The largest diameter of lesion ≥ 2 cmHepatic vein/portal cancer embolus
Age of patients ≥ 18 yrInferior vena cava embolus
Inability of informed written consent